Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | CBFB | Q13951 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12121753 | 0.85 | DAO (0.36) | — | |
| SCHEMBL14730924 | 0.85 | — | — | |
| SCHEMBL25247956 | 0.83 | ILK (0.33) | — | |
| SCHEMBL2589396 | 0.83 | EGLN1 (0.34) | — | |
| SCHEMBL28695956 | 0.83 | MAPT (0.43) | ALDH1A1GPR84MAPT | |
| SCHEMBL26449991 | 0.83 | DAO (0.35) | KDM4EMAPT | |
| SCHEMBL8568181 | 0.83 | MAPT (0.52) | ALDH1A1GPR84MAPT | |
| SCHEMBL12180644 | 0.83 | MAPT (0.35) | KDM4EALDH1A1CYP2C9CYP2C19HSD17B10 | |
| SCHEMBL2705071 | 0.79 | — | — | |
| SCHEMBL23845783 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120035304-A | Perovskite solar cell and crystal surface defect passivation method thereof | 中国长江三峡集团有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119241454-A | Fluorescent material of 5, 6-difluoro benzotriazoles derivative and application thereof | 南京欧纳壹有机光电有限公司 | 2025-01-03 | — | — | CN | claimed |
| WO-2025264724-A1 | MPRO INHIBITORS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4660199-A1 | 19-NOR NEUROACTIVE STEROIDS FOR INDUCING SEDATION | Sage Therapeutics, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| CN-120035304-A | Perovskite solar cell and crystal surface defect passivation method thereof | 中国长江三峡集团有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-116041672-B | Polymer based on 4-alkylthio thiophene/4-alkylseleno thiophene, preparation method and application | 南方科技大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-119241454-A | Fluorescent material of 5, 6-difluoro benzotriazoles derivative and application thereof | 南京欧纳壹有机光电有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119241454-A | Fluorescent material of 5, 6-difluoro benzotriazoles derivative and application thereof | 南京欧纳壹有机光电有限公司 | 2025-01-03 | — | — | CN | disclosed |
| EP-3719030-B1 | 19-NOR NEUROACTIVE STEROIDS FOR INDUCING SEDATION | SAGE THERAPEUTICS INC (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-117304245-A | 19-nor steroids that stimulate neural activity and methods of use thereof | 萨奇治疗股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-112110976-B | 19-nor steroids that stimulate neural activity and methods of use thereof | 萨奇治疗股份有限公司 | 2023-08-29 | — | — | CN | disclosed |
| US-20130092912-A1 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2013-04-18 | — | — | US | disclosed |
| US-20120319097-A1 | ELECTRODE TREATMENT PROCESS FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-20 | — | — | US | disclosed |
| US-20120277237-A1 | NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | ADDEX PHARMA SA (CH) | 2012-11-01 | — | — | US | disclosed |
| EP-2426115-A2 | Alkynyl derivatives as modulators of metabotropic glutamate receptors | Addex Pharma SA (CH) | 2012-03-07 | — | — | EP | disclosed |
| US-8101637-B2 | Alkynyl derivatives as modulators of metatropic glutamate receptors | ADDEX PHARMA SA (CH) | 2012-01-24 | — | — | US | disclosed |
| WO-2011156478-A2 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011156478-A2 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011103952-A1 | ELECTRODE TREATMENT PROCESS FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-09-01 | — | — | WO | disclosed |
| US-20090124625-A1 | NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METATROPIC GLUTAMATE RECEPTORS | ADDEX PHARMACEUTICALS SA (CH) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124625-A1 | NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METATROPIC GLUTAMATE RECEPTORS | GRM5, GRM2, GRM1 | KDM4E 1986/4885ALDH1A1 2496/4885CYP1A2 3019/4885 |
| US-20130092912-A1 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | GJB2, PARG, PARN | KDM4E 4406/4885ALDH1A1 1406/4885CYP1A2 2777/4885 |
| US-20120277237-A1 | NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | GRM5, GRM1, GRM2 | KDM4E 1750/4885ALDH1A1 2153/4885CYP1A2 3599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.